| Related Articles |
Denosumab is a long-term option for the management of parathyroid carcinoma-related refractory hypercalcemia.
QJM. 2016 Dec 22;:
Authors: Fountas A, Tigas S, Tsatsoulis A
PMID: 28011856 [PubMed - as supplied by publisher]
http://ift.tt/2i7dA5H
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου